Secretin Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with secretin
R
- Ralix (chlorpheniramine / methscopolamine / phenylephrine)
- Re-Drylex (dexchlorpheniramine / methscopolamine / phenylephrine)
- Re-Drylex Jr (chlorpheniramine / methscopolamine / phenylephrine)
- RE-PB Hyos Elixir (atropine / hyoscyamine / phenobarbital / scopolamine)
- Redur-PCM (chlorpheniramine / methscopolamine / phenylephrine)
- RelCof CPM (chlorpheniramine / methscopolamine)
- RelCof DN PE (chlorpheniramine / methscopolamine / phenylephrine)
- RelCof DN PSE (chlorpheniramine / methscopolamine / pseudoephedrine)
- RelCof PE (chlorpheniramine / methscopolamine / phenylephrine)
- Relcof PSE (chlorpheniramine / methscopolamine / pseudoephedrine)
- Rescon Extended Release (chlorpheniramine / methscopolamine / phenylephrine)
- Respa-AR (atropine / chlorpheniramine / hyoscyamine / pseudoephedrine / scopolamine)
- RespiVent DF (chlorpheniramine / methscopolamine)
- Respivent-D (methscopolamine / pseudoephedrine)
- Rhinaclear (chlorpheniramine / methscopolamine / pseudoephedrine)
- Rhinolar (chlorpheniramine / methscopolamine / phenylpropanolamine)
- Robinul (glycopyrrolate)
- Robinul Forte (glycopyrrolate)
- Rolatuss-SR (atropine / chlorpheniramine / hyoscyamine / phenylephrine / phenylpropanolamine / scopolamine)
- Ru-Tuss (atropine / chlorpheniramine / hyoscyamine / pseudoephedrine / scopolamine)
- Ryneze (chlorpheniramine / methscopolamine)
More about secretin
- secretin consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: in vivo diagnostic biologicals
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.